Uni-Bio Science Group Limited (00690.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.5x

Market Cap

HKD 359.42M

MomentumView details →

1D Return

+3.45%

YTD Return

−47.83%

RSI (14)

38.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.5x

Market Cap

HKD 359.42M

RSI (14)

38.5

MomentumView details →

1D Return

+3.45%

YTD Return

−47.83%

ProfitabilityView details →

Gross Margin

82.44%

Net Margin

12.28%

EBITDA Margin

16.70%

ROE (TTM)

31.18%

ROA (TTM)

23.10%

Asset Turnover

1.92x

GrowthView details →

Revenue YoY

+13.59%

EPS YoY

−9.69%

FCF YoY

−83.82%

Revenue CAGR 3Y

+10.01%

EPS CAGR 3Y

+36.75%

EBITDA YoY

−8.08%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.19x

Current Ratio

2.93x

Quick Ratio

2.55x

Div Yield

5.22%

Div Rate

HKD 0.00

Div Growth 1Y

+13.00%

Financials snapshotView financials →

Revenue (TTM)

1.14B

Net Income (TTM)

139.89M

Op. CF (TTM)

114.40M

Latest newsMore news →

Uni-Bio Science Group Limited announced its interim results for the six months ended 30 June 2026, reporting revenue of approximately HK$273.8 million and net profit of approximately HK$31.2 million.9d ago

Similar companies

Sirnaomics Ltd.02257.HK Q32 Bio Inc.QTTB DiaMedica Therapeutics Inc.DMAC Palisade Bio, Inc.PALI Lyell Immunopharma, Inc.LYEL Alpha Tau Medical Ltd.DRTSW Find similar companies →

Latest newsMore news →

Uni-Bio Science Group Limited announced its interim results for the six months ended 30 June 2026, reporting revenue of approximately HK$273.8 million and net profit of approximately HK$31.2 million.9d ago